VALIRX PLC Logo

VALIRX PLC

Life science company developing therapeutics for oncology and women's health.

VAL | IL

Overview

Corporate Details

ISIN(s):
GB00BLH13C52
LEI:
213800VQKB9SJCQDET40
Country:
United Kingdom
Address:
STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH

Description

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-05 10:53
Update on Evaluation Agreement with Stingray Bio
English 17.9 KB
2025-08-04 08:00
Licensing Agreement with Dominion Biotech Ltd
English 16.3 KB
2025-07-29 08:00
Collaboration Agreement with Voxcell BioInnovation
English 17.2 KB
2025-06-20 08:00
Ambrose Exercise Option on VAL401
English 16.9 KB
2025-06-06 11:54
Holding(s) in Company
English 54.3 KB
2025-06-06 08:00
Final Results & Notice of AGM
English 174.1 KB
2025-06-03 08:00
New Evaluation and Material Transfer Agreement
English 15.3 KB
2025-03-27 08:00
Directorate Changes and new Advisory Board
English 20.7 KB
2025-02-24 08:00
Conclusion of Evaluation Project
English 15.0 KB
2025-02-03 08:00
Inaphaea Evaluation and Commercial Use Agreement
English 17.0 KB
2025-01-30 08:00
Extension of Evaluation Agreement
English 15.0 KB
2025-01-29 08:00
New Evaluation and Option Agreement
English 15.5 KB
2025-01-15 13:47
Holding(s) in Company
English 22.1 KB
2025-01-15 12:29
Holding(s) in Company
English 54.3 KB
2025-01-14 08:00
Holding(s) in Company
English 21.9 KB

Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VALIRX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VALIRX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.